AstraZeneca Pharma said the receipt of this permission paves way for the launch of Benralizumab (Fasenra) in India, subject to the receipt of related statutory approvals and licenses.
from Industry-Economic Times https://ift.tt/3nExsf1
via IFTTT
AstraZeneca Pharma gets DCGI nod to market asthma drug
Reviewed by Globez News Today
on
December 20, 2020
Rating: 5
No comments:
For Further Information, kindly click here!